Arroyo Pereiro, Pablo
Muñoz-Vendrell, Albert
León Moreno, Isabel
Bau, Laura
Matas, Elisabet
Romero-Pinel, Lucía
Martínez Yélamos, Antonio
Martínez Yélamos, Sergio
Andrés-Benito, Pol http://orcid.org/0000-0003-3000-0338
Article History
Received: 8 October 2023
Revised: 21 November 2023
Accepted: 22 November 2023
First Online: 12 December 2023
Declarations
:
: Pablo Arroyo-Pereiro, Albert Muñoz-Vendrell, Isabel León, Antonio Martínez-Yélamos and Sergio Martínez-Yélamos received honoraria for participating on advisory boards and for collaborations as consultants and scientific communications; they also received research support as well as funding for travel and congress expenses from Roche, Biogen Idec, Novartis, TEVA, Merck, Genzyme, Sanofi, Bayer, Almirall, and Celgene. Pol Andrés-Benito received research support funding from Biogen Iberica S.L.
: This study was approved by the Hospital Universitari de Bellvitge Research Ethics Committee, with reference PR257/23. Patients signed informed consent forms, and data were collected anonymously. Patient information confidentiality was handled in accordance with Spanish regulations.